<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The biology of IgE</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The biology of IgE</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">The biology of IgE</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeff Stokes, MD, FAAAAI, FACAAI</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas B Casale, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruce S Bochner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 19, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H13745029"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The pathogenesis of many allergic diseases involves "allergic" antibody or immunoglobulin E (IgE) [<a href="#rid1">1</a>]. This topic will review the structure, biology, and functions of IgE. A review of the role of IgE in allergic diseases and more general discussions of immunoglobulin structure and function are found elsewhere. (See  <a class="medical medical_review" href="/d/html/83038.html" rel="external">"The relationship between IgE and allergic disease"</a> and  <a class="medical medical_review" href="/d/html/3971.html" rel="external">"Structure of immunoglobulins"</a> and  <a class="medical medical_review" href="/d/html/3970.html" rel="external">"Overview of therapeutic monoclonal antibodies"</a>.)</p><p class="headingAnchor" id="H13745037"><span class="h1">ROLES OF IgE</span><span class="headingEndMark"> — </span>IgE is important in defense against parasitic diseases, especially those caused by helminths and some protozoa [<a href="#rid2">2,3</a>]. However, due in part to the redundancy of the immune system, low or absent levels of IgE do not predispose people to severe parasitic infections [<a href="#rid4">4</a>]. IgE is <strong>not</strong> believed to play an important role in defense against bacterial infections, since it does not activate complement or participate in opsonization [<a href="#rid5">5</a>]. IgE plays a key role in the pathogenesis of allergic diseases, especially mast cell/basophil activation, and in antigen presentation.</p><p class="headingAnchor" id="H13745045"><span class="h1">STRUCTURE</span><span class="headingEndMark"> — </span>IgE is one of five isotypes of human immunoglobulins: IgG, IgA, IgM, IgD, and IgE [<a href="#rid6">6,7</a>]. All immunoglobulins are composed of two light chains and two identical heavy chains (<a class="graphic graphic_figure graphicRef83423" href="/d/graphic/83423.html" rel="external">figure 1</a>). The heavy chain differentiates the various immunoglobulin isotypes. The heavy chain in IgE is epsilon. IgE is a monomer and consists of four constant regions in contrast with other immunoglobulins that contain only three constant regions. Due to this extra region, the weight of IgE is 190 kDa compared with 150 kDa for IgG.</p><p>The C-epsilon-2 constant domain is unique to IgE, while the C-epsilon-3 region binds to the low- and high-affinity IgE receptor. Of note, the anti-IgE monoclonal antibody <a class="drug drug_general" data-topicid="10251" href="/d/drug information/10251.html" rel="external">omalizumab</a> also binds to the C-epsilon-3 region, so the binding of omalizumab to IgE decreases the amount of "free" IgE available for binding to IgE receptor-bearing cells, including mast cells and basophils (<a class="graphic graphic_figure graphicRef83423" href="/d/graphic/83423.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/d/html/545.html" rel="external">"Anti-IgE therapy"</a>.)</p><p class="headingAnchor" id="H13745053"><span class="h1">SYNTHESIS</span><span class="headingEndMark"> — </span>Antibodies are produced by B cells. These cells are programmed to make IgM by default but undergo "isotype switching" to produce IgE with the same antigenic specificity under certain conditions. This process requires cell surface interactions between B and T cells, as well as soluble factors from various cell types [<a href="#rid1">1,8-10</a>]. During isotype switching, genomic DNA is spliced and rejoined in class-switch recombination. (See  <a class="medical medical_review" href="/d/html/3977.html" rel="external">"Immunoglobulin genetics"</a>.)</p><p>B cell isotype switching requires two signals:</p><p class="bulletIndent1"><span class="glyph">●</span>The first signal involves the soluble factors interleukin (IL-) 4 and IL-13 released by a number of inflammatory cells, including T helper type 2 (Th2) cells, innate lymphoid cells, mast cells, and basophils. Interaction of these cytokines with their respective receptors on B cells activates transcription at the specific epsilon germline locus via signal transducer and activator of transcription (STAT)6.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The second signal is the interaction between the B cell CD40 (cluster of differentiation 40, a member of the tumor necrosis factor receptor superfamily) and T cell CD40 ligand (CD154). The second signal results in DNA class-switch recombination and IgE expression triggered by nuclear factor-kappa-B (NF-kappa-B). STAT6 and NF-kappa-B synergize to activate B cell activator protein, promoting production of IgE. The removal of the unwanted constant regions by splicing and rejoining of the DNA requires activation-induced cytidine deaminase and uracil DNA glycosylase. Accessory signals that amplify IgE production include CD28/CD80-CD86 interactions. In addition, there are negative signals that reduce IgE production: inhibitor of DNA-binding-2 binds to E-box, B cell lymphoma 6 competes with STAT6, and suppressor of cytokine signaling-1 (SOCS-1) also works on STAT6. Interferon-gamma can also inhibit IgE production via STAT1-mediated activation of SOCS-1.</p><p></p><p>B cell isotype switching to produce antigen-specific IgE occurs primarily in mucosal lymphoid tissues, with the greatest amounts of antigen-specific IgE production in tonsils and adenoids, although some also occur in peripheral tissues [<a href="#rid11">11,12</a>]. The newly formed IgE then diffuses through the tissues and into the circulation (<a class="graphic graphic_figure graphicRef55328" href="/d/graphic/55328.html" rel="external">figure 2</a>).</p><p>There is some evidence that IgE may be produced outside of the classic Th2 cell-dependent pathway. In T cell-deficient knockout mice, IgE was produced independent of major histocompatibility complex class II cells, possibly due to CD4+ gamma-delta T cells. The exact mechanism of production of IgE stimulated by bacterial superantigens may also result from an atypical pathway. The cross-linking of basophils by IgD is another possible mechanism of nontraditional IgE production [<a href="#rid13">13</a>]. Finally, regulatory follicular helper cells (Tfr) and Tfh13 cells are important in the production of low- and high-affinity short-lived IgE plasma cells, respectively [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H1397010"><span class="h2">Localized IgE production</span><span class="headingEndMark"> — </span>Antigen-specific IgE production occurs locally within the bronchial and nasal mucosa, in addition to the lymphoid tissues and bone marrow, even in patients who are considered nonatopic by skin testing and laboratory tests [<a href="#rid15">15-19</a>]. One study suggested that more than 99 percent of circulating allergen-specific IgE was produced within the tissues [<a href="#rid12">12</a>]. This phenomenon of local IgE production is termed "entopy" and may underlie some cases of chronic "nonallergic" rhinitis and severe asthma [<a href="#rid20">20,21</a>].</p><p>There is some evidence that a small number of IgE-producing plasma cells or memory B cells reside in the bone marrow or spleen. Reports of patients acquiring the food or drug allergies of donors following bone marrow transplantation support this concept, although this phenomenon is not consistently observed and may be uncommon [<a href="#rid22">22-26</a>].</p><p class="headingAnchor" id="H264545938"><span class="h2">Regulation of synthesis</span><span class="headingEndMark"> — </span>The genetic predisposition to develop allergic disease, or atopy, is a complex trait that is not fully understood. Total serum IgE levels and regulation of serum IgE production are strongly influenced by genetic factors. Less is known about other genetic factors important for the development of allergic disease. Genome-wide association studies have identified several loci that may be important for IgE regulation, including loci in the gene encoding the alpha chain of the high-affinity receptor for IgE (FC-epsilon-RI-alpha), STAT6, and in the gene <em>RAD50</em>/IL-13 cluster [<a href="#rid27">27-29</a>].</p><p>Once an individual is producing IgE to a specific allergen, exposure to that allergen usually boosts production of IgE to it. For example, nasal challenge with allergen on two successive days can boost production of allergen-specific IgE as much as 40 percent [<a href="#rid30">30,31</a>]. This mechanism underlies the seasonal increases in serum levels of pollen-specific IgE seen in patients with pollen allergy and also explains why drug allergies can resolve if a patient is able to successfully avoid the culprit drug for years.</p><p class="headingAnchor" id="H13745061"><span class="h1">IgE RECEPTORS</span><span class="headingEndMark"> — </span>IgE functions through its high- and low-affinity receptors on mast cells, basophils, and other cells leading to degranulation of mast cells and basophils and antigen presentation [<a href="#rid1">1,5,11,13</a>]. Expression of both receptors is enhanced by IgE-binding, so circulating IgE levels are positively correlated with receptor levels.</p><p class="headingAnchor" id="H13745069"><span class="h2">High-affinity receptor</span><span class="headingEndMark"> — </span>The high-affinity receptor for IgE is Fc-epsilon-RI. IgE binds to the alpha chain [<a href="#rid5">5</a>]. Fc-epsilon-RI exists in two forms:</p><p class="bulletIndent1"><span class="glyph">●</span>A tetrameric form (alpha-beta-gamma<sub>2</sub>) of Fc-epsilon-RI is expressed on mast cells and basophils. In the nonactivated state, these cells are coated with Fc-epsilon-RI receptors bound to various antigen-specific IgE molecules. If that multivalent antigen (allergen) enters the cell's environment, it binds to the IgE, causing the Fc-epsilon-RI receptors to cluster on the cell surface and become cross-linked. IgE glycosylation is required for binding to the Fc-epsilon-RI receptor [<a href="#rid32">32</a>]. Cross-linking leads to activation of the cell and release of preformed mediators from cytoplasmic granules (eg, histamine), transcription and release of cytokines, and synthesis of leukotrienes and prostaglandins [<a href="#rid9">9</a>]. The strength of the activation signal depends on the polyvalency of the allergen (ie, number of binding sites for IgE) and the affinity of the IgE for the allergen. The inflammatory mediators released by mast cells and basophils include histamine, tryptases, and tumor necrosis factor-alpha, as well as leukotrienes and prostaglandins (LTC<sub>4</sub> and PGD<sub>2</sub>, respectively). These mediators are responsible for the signs and symptoms of immediate hypersensitivity. In addition, production of the T helper type 2 (Th2) cytokines interleukin (IL-) 4, IL-5, and IL-13, initiates late-phase inflammation and promotes more IgE production. These mechanisms underlie the clinical manifestations of allergic diseases, such as allergic rhinitis and conjunctivitis, allergic asthma, food allergy, and anaphylaxis. The mediators released by mast cells are reviewed in more detail separately. (See  <a class="medical medical_review" href="/d/html/3972.html" rel="external">"Mast cell-derived mediators"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A trimeric form of Fc-epsilon-RI (alpha-gamma<sub>2</sub>) can be expressed on human Langerhans cells, dendritic cells, and monocytes. In humans, it is theorized that Fc-epsilon-RI on antigen-presenting cells permits the transport of antigens captured by IgE in the tissues into peripheral lymph nodes to initiate immune responses. A truncated, soluble form of Fc-epsilon-RI alpha also exists, which may be released from dendritic cells following cross-linking of cell surface Fc-epsilon-RI by allergen, and can act to bind IgE and allergen/IgE complexes, thus preventing further activation of mast cells and basophils [<a href="#rid33">33</a>]. Thus, soluble form of Fc-epsilon-RI alpha, if present in high enough concentrations, may be a negative regulator of IgE-mediated allergic reactions or a naturally occurring analog of <a class="drug drug_general" data-topicid="10251" href="/d/drug information/10251.html" rel="external">omalizumab</a>, as they both compete for the same binding domain on IgE and evidence suggests that soluble Fc-epsilon-RI can also result in decreased Fc-epsilon-RI alpha expression on allergic and other effector cells.</p><p></p><p class="headingAnchor" id="H13745077"><span class="h2">Low-affinity receptor</span><span class="headingEndMark"> — </span>The low-affinity IgE receptor, Fc-epsilon-RII (CD23), is present on a variety of cells [<a href="#rid10">10</a>]. The constitutively expressed form, CD23a, is present only on B cells, while the inducible form, CD23b, is present on B cells, T cells, dendritic cells, monocytes, macrophages, neutrophils, eosinophils, intestinal epithelial cells, and platelets [<a href="#rid34">34,35</a>].</p><p>Functions include regulation of IgE synthesis (binding of IgE to B cell CD23 inhibits IgE synthesis), antigen capture and presentation, and growth and differentiation of B cells. The stalk region on CD23 is critical for IgE-binding and can be blocked by anti-IgE antibodies [<a href="#rid36">36</a>]. Epithelial cell CD23 transports IgE allergen complexes from the apical to the basolateral surface of respiratory and gastrointestinal epithelium, bringing inhaled and ingested allergens into contact with mast cells residing in the mucosa [<a href="#rid10">10</a>]. CD23 can be shed from the cell membrane by endogenous proteases, creating a soluble form (sCD23) that may be important for upregulation of IgE synthesis [<a href="#rid37">37,38</a>].</p><p class="headingAnchor" id="H13745085"><span class="h1">MEASUREMENT OF IgE</span></p><p class="headingAnchor" id="H13745093"><span class="h2">Total IgE</span><span class="headingEndMark"> — </span>Total IgE levels are frequently measured by a sandwich-type assay. In this method, anti-IgE antibody is bound to a solid support [<a href="#rid39">39</a>]. Serum from a patient is added, and then unbound protein is washed away. A second labeled anti-IgE antibody is added, and the amount bound to the patient's IgE is measured. Total serum IgE levels are reported as international units or nanograms per milliliter (1 international unit/mL = 2.44 ng/mL) [<a href="#rid40">40,41</a>]. IgE assays are calibrated in kU/L against the third World Health Organization IgE International Reference Preparation [<a href="#rid42">42</a>].</p><p class="headingAnchor" id="H13745101"><span class="h2">Allergen-specific IgE</span><span class="headingEndMark"> — </span>The first commercial assay for allergen-specific IgE was the radioallergosorbent test (RAST) [<a href="#rid39">39-41</a>]. The bound allergen-specific IgE was detected with radioiodinated polyclonal antihuman IgE and quantified with a gamma counter. The term "RAST" is still frequently used to refer to in vitro assays for allergen-specific IgE, although modern methods use enzymes instead of radionucleotides. A number of other technical advances in assay technology have dramatically improved the sensitivity and specificity of allergen-specific IgE measurements. The terms "in vitro IgE antibody assay" or "allergen-specific IgE immunoassay" more accurately characterize the three IgE antibody assays clinically available in North America [<a href="#rid41">41</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The HYTEC-288 is a colorimetric assay using a paper disc solid-phase support. It is being replaced by the Falcon autoanalyzer.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The ImmunoCAP is a fluoroimmunoassay with a cellulose sponge solid-phase matrix.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Immulite chemiluminescent assay has a biotinylated allergen and avidin particle solid phase.</p><p></p><p>These three autoanalyzers use extracts from different sources immobilized as the antigen capture allergosorbent, and, thus, their results are not interchangeable. Select allergenic components have also been immobilized for use in component-resolved diagnosis. These tests quantify allergen-specific IgE, which confirms sensitization but may or may not correlate with allergic disease or specific symptoms. The use of immunoassays in the diagnosis of allergic disease is reviewed separately. (See  <a class="medical medical_review" href="/d/html/5540.html" rel="external">"Overview of in vitro allergy tests", section on 'Immunoassays for allergen-specific IgE'</a>.)</p><p>The lower limit of detection for allergen-specific IgE is lower than that for total IgE. Most laboratories employ a lower limit of approximately 0.1 to 0.35 international units/mL, where 1 international unit = 2.4 ng of IgE.</p><p class="headingAnchor" id="H15831806"><span class="h2">Effect of omalizumab</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10251" href="/d/drug information/10251.html" rel="external">Omalizumab</a>, the monoclonal anti-IgE antibody, binds to free serum IgE and forms immune complexes that increase circulating total IgE levels five- to sixfold. The accuracy of most in vitro assays for total serum IgE is compromised by the presence of omalizumab, although one commercially available system (ImmunoCAP) retains reasonable accuracy for both total and allergen-specific IgE measurements in the presence of omalizumab [<a href="#rid43">43</a>]. Note that none of the clinically used total serum IgE assays measure "free" IgE in the presence of omalizumab. Rather, it is the level of total IgE (free and omalizumab bound) that is assessed [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/545.html" rel="external">"Anti-IgE therapy", section on 'Other changes with therapy'</a>.)</p><p class="headingAnchor" id="H13745109"><span class="h1">IgE LEVELS</span></p><p class="headingAnchor" id="H13745117"><span class="h2">Normal levels</span><span class="headingEndMark"> — </span>IgE has the lowest serum concentration of all of the immunoglobulins, approximately 150 ng/mL (about 62 international units/mL), which is approximately 66,000-fold lower than the serum concentration of IgG (typically 10 mg/mL) [<a href="#rid5">5,13</a>]. Normal serum levels range from approximately 0 to 100 international units/mL (sometimes expressed in kU/L, depending upon the laboratory). However, a 2014 study of 1376 healthy children and 128 adults in the United States using the ImmunoCAP 1000 instrument found that normal adult levels ranged from 2 to 214 international units/mL [<a href="#rid44">44</a>]. The upper limit of normal in this study was significantly higher than the upper limit of normal established years before and used in most commercial laboratories, although the authors noted that the nonatopic status of these subjects was based solely on self-reported clinical history.</p><p>The half-life of free IgE in the serum is about two days, although once IgE has bound to mast cells, the half-life is extended to about two weeks due to the high affinity of this interaction [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H13745125"><span class="h2">Childhood levels</span><span class="headingEndMark"> — </span>IgE is not believed to cross the placenta. Therefore, a female's allergen sensitivities are not passed on directly to her offspring through IgE transfer. However, allergens can be passed transplacentally, and the fetus can produce allergen-specific IgE. Routine allergen-specific IgE immunoassays cannot distinguish infant from maternal IgE, although a highly sensitive investigational microarray technique has demonstrated that infants can have IgE specific to food and inhalant allergens already present at birth [<a href="#rid45">45</a>].</p><p>Levels increase from birth and peak during adolescence (<a class="graphic graphic_figure graphicRef83424" href="/d/graphic/83424.html" rel="external">figure 3</a>) [<a href="#rid44">44,46</a>]. Preschool levels do not correlate well with those at older ages. Factors associated with increased levels of total IgE include male sex, African-American race, poverty, increased serum cotinine (reflecting tobacco smoke exposure), less than a 12<sup>th</sup> grade education, and obesity [<a href="#rid46">46</a>]. However, the 2014 study did not find sex differences in IgE levels [<a href="#rid44">44</a>].</p><p>In atopic individuals, total serum IgE levels may fluctuate. For example, in pollen-sensitized individuals, serum IgE levels peak four to six weeks after the height of pollen season and subsequently decline until the next pollen season [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H13745133"><span class="h3">Breastfeeding</span><span class="headingEndMark"> — </span>Human breast milk has negligible amounts of IgE [<a href="#rid47">47,48</a>]. However, the serum IgE level of a breastfeeding mother appears to influence the serum level of her infant. Children of mothers with high IgE levels who breastfed their children for four months or longer had higher total IgE levels than bottle-fed infants or infants breastfed for less than four months [<a href="#rid49">49</a>]. In contrast, breastfed infants of mothers with low IgE levels were more likely to have lower IgE levels than the bottle-fed or less than four months of breastfeeding infants. Paternal IgE levels did not have a detectable influence on children's IgE levels.</p><p class="headingAnchor" id="H13745141"><span class="h2">Decreased total IgE</span><span class="headingEndMark"> — </span>Most assays can only detect IgE levels as low as 2 to 5 international units/mL, with lower levels characterized as undetectable. Accordingly, IgE deficiency had been defined as levels &lt;2.5 international units/mL.</p><p>In humans, decreased IgE levels can be associated with low levels of other immunoglobulins with sinopulmonary disease and with an increased prevalence of autoimmune diseases [<a href="#rid50">50,51</a>]. It is unclear if isolated IgE deficiency in humans is a clinically relevant immunodeficiency or a marker of more general immune dysregulation. The clinical manifestations of selective IgE deficiency are reviewed separately. (See  <a class="medical medical_review" href="/d/html/3947.html" rel="external">"Clinical significance of isolated IgE deficiency"</a>.)</p><p class="headingAnchor" id="H13745149"><span class="h2">Increased total IgE</span><span class="headingEndMark"> — </span>Increased serum IgE is seen in allergic diseases, some primary immunodeficiencies, parasitic and viral infections, certain inflammatory diseases, some malignancies, and a few other disorders (<a class="graphic graphic_table graphicRef83457" href="/d/graphic/83457.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H13745157"><span class="h3">Atopic disorders</span><span class="headingEndMark"> — </span>Increased serum IgE is associated with allergic and respiratory diseases, such as atopic dermatitis, allergic bronchopulmonary aspergillosis, asthma, persistent wheezing in children, and airway hyper-responsiveness [<a href="#rid5">5,11</a>]. (See  <a class="medical medical_review" href="/d/html/83038.html" rel="external">"The relationship between IgE and allergic disease", section on 'Elevated total serum IgE'</a>.)</p><p class="headingAnchor" id="H13745166"><span class="h3">Immunodeficiencies</span><span class="headingEndMark"> — </span>Several primary immunodeficiencies are associated with elevated levels of IgE [<a href="#rid5">5,11,52-56</a>]. It is unclear what pathologic role, if any, the increased IgE level has in these disorders.</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with autosomal dominant hyperimmunoglobulin E syndrome (Job syndrome) caused by variants of the signal transducer and activator of transcription (<em>Stat)3</em> gene have increased total IgE, usually ranging from 2000 to &gt;50,000 international units/mL. This form of hyperimmunoglobulin E syndrome is characterized by eczema, retained primary teeth, joint hyperextensibility, characteristic facies, and pathologic fractures. These patients are more susceptible to fungal and <em>Staphylococcus aureus </em>infections of the skin (skin abscesses) and lungs, including pneumatoceles. Autosomal recessive forms of hyperimmunoglobulin E syndrome have also been described including tyrosine kinase 2 gene (<em>Tyk2</em>) and dedicator of cytokinesis 8 gene (<em>DOCK8</em>) deficiencies. The list of variants that can give rise to a hyperimmunoglobulin E syndrome continues to expand, as discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/3960.html" rel="external">"Autosomal dominant hyperimmunoglobulin E syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Netherton syndrome (cutaneous ichthyosis) is a rare autosomal recessive disorder due to a deficiency in serum peptidase inhibitor, Kazal type 5 (SPINK5) leading to IgE sensitization via a damaged skin barrier. Total IgE levels may range from 100 to over 10,000 international units/mL. Presentation may be similar to hyperimmunoglobulin E syndrome, except that ichthyosis and bamboo hair (<em>Trichorrhexis invaginata</em>) occur in Netherton syndrome. (See  <a class="medical medical_review" href="/d/html/15474.html" rel="external">"Netherton syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is a rare X-linked primary immunodeficiency with autoimmunity caused by loss of function of the transcription factor Foxp3 and is composed of a triad of enteropathy, endocrinopathy (diabetes or hypothyroid), and eczema. Patients have increased IgE and IgA with reduced or absent T regulatory cells. (See  <a class="medical medical_review" href="/d/html/3924.html" rel="external">"IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Wiskott-Aldrich syndrome, a rare X-linked syndrome due to variants in the Wiskott-Aldrich syndrome protein, is associated with eczema, thrombocytopenia, variable T cell function, and increased IgE levels. (See  <a class="medical medical_review" href="/d/html/3953.html" rel="external">"Wiskott-Aldrich syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Omenn syndrome presents with erythroderma, failure to thrive, diarrhea, hepatosplenomegaly, lymphadenopathy, eosinophilia, increased IgE, and decreased IgG, IgA, and IgM. Omenn syndrome is a combined B and T cell immunodeficiency due to hypomorphic variants in recombination-activating gene (<em>RAG)1, RAG2</em>, or Artemis<em>,</em> altering T cell receptor rearrangement. (See  <a class="medical medical_review" href="/d/html/3950.html" rel="external">"T-B-NK+ SCID: Pathogenesis, clinical manifestations, and diagnosis", section on 'T-B-NK+ SCID without radiation sensitivity due to RAG defects (includes most cases of Omenn syndrome)'</a> and  <a class="medical medical_review" href="/d/html/3950.html" rel="external">"T-B-NK+ SCID: Pathogenesis, clinical manifestations, and diagnosis", section on 'Omenn syndrome phenotype'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One phenotype of complete DiGeorge syndrome has oligoclonal T cell expansion with elevated IgE levels, in addition to the classic midline deficits (thymic hypoplasia, cardiac defects, parathyroid disease, cleft palate, and classic facies). (See  <a class="medical medical_review" href="/d/html/3905.html" rel="external">"DiGeorge (22q11.2 deletion) syndrome: Epidemiology and pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/3909.html" rel="external">"DiGeorge (22q11.2 deletion) syndrome: Management and prognosis"</a>.)</p><p></p><p class="headingAnchor" id="H13745174"><span class="h3">Infections</span><span class="headingEndMark"> — </span>Infections with certain parasites and viruses are associated with an elevated serum IgE. In the developing world, parasitic infection is the most common cause of elevations in IgE [<a href="#rid5">5,11,53</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>A primary role for IgE is combating parasitic diseases. Parasites that are known to increase serum IgE include <em>Strongyloides</em>, <em>Toxocara</em>, <em>Trichuris</em>, <em>Ascaris</em>, <em>Echinococcus</em>, hookworms, filaria, and <em>Schistosoma</em>. Increased IgE levels reflect both parasite-specific IgE and total IgE [<a href="#rid57">57,58</a>]. Increasing levels of IgE appear associated with increasing tissue invasion [<a href="#rid11">11</a>]. A peripheral blood eosinophilia is usually also present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with HIV type 1 have elevated IgE levels as well as increased allergic reactions to drugs or environmental allergens [<a href="#rid11">11,59,60</a>]. In adults with HIV, elevated IgE levels may be partially related to various other conditions, such as intravenous drug use and alcohol intake [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Viral infections associated with elevated IgE levels include Epstein-Barr virus (EBV) and cytomegalovirus. In EBV mononucleosis, IgE levels increase initially and return to baseline within weeks to months [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Elevated IgE levels may be seen in infections with <em>Mycobacterium tuberculosis</em> [<a href="#rid63">63-65</a>].</p><p></p><p class="headingAnchor" id="H13745182"><span class="h3">Inflammatory diseases</span><span class="headingEndMark"> — </span>Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) features include elevated IgE (up to 5000 international units/mL), as well as necrotizing small- and medium-sized vessel vasculitis and eosinophilia associated with asthma. (See  <a class="medical medical_review" href="/d/html/4347.html" rel="external">"Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)"</a>.)</p><p>Kimura disease is a rare, benign chronic inflammatory disorder with lymphadenopathy and eosinophilic adenitis of the head and neck regions of middle-aged Asian males. In addition to IgE levels greater than 1000 international units/mL, peripheral eosinophilia is present [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/d/html/100544.html" rel="external">"Eosinophil biology and causes of eosinophilia", section on 'Disorders with eosinophilic involvement of specific organs'</a>.)</p><p class="headingAnchor" id="H13745190"><span class="h3">Neoplasms</span><span class="headingEndMark"> — </span>Neoplasms that have been reported in association with elevations in IgE include Hodgkin and non-Hodgkin lymphoma [<a href="#rid67">67-70</a>], especially nodular sclerotic histology, cutaneous T cell lymphoma/Sézary syndrome [<a href="#rid71">71,72</a>], and IgE myeloma [<a href="#rid53">53</a>]. IgE myelomas are extremely rare (0.01 percent of plasmacytomas), with serum IgE levels ranging from 0.6 to 63 g/L [<a href="#rid11">11,73-77</a>].</p><p class="headingAnchor" id="H13745198"><span class="h3">Other disorders</span></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with bone marrow transplantation, IgE levels can increase up to 2000-fold, even in patients without graft-versus-host disease [<a href="#rid78">78,79</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nephrotic syndrome associated with different forms of glomerulonephritis is associated with increased levels of IgE that decrease with therapy [<a href="#rid80">80-82</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cigarette smokers often have increased IgE levels compared with nonsmokers, especially in males [<a href="#rid83">83,84</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alcohol consumption increases serum IgE levels but does not increase the risk of allergic disease [<a href="#rid85">85-87</a>].</p><p></p><p class="headingAnchor" id="H13745206"><span class="h1">ANTI-IgE THERAPY</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10251" href="/d/drug information/10251.html" rel="external">Omalizumab</a> is a recombinant humanized monoclonal antibody that binds to the C-epsilon-3 portion of free serum IgE. It is approved for the treatment of perennial moderate-to-severe chronic persistent allergic asthma in patients six and older and for chronic antihistamine-resistant urticaria. It has been shown to be effective for other IgE-mediated diseases as well. (See  <a class="medical medical_review" href="/d/html/545.html" rel="external">"Anti-IgE therapy"</a>.)</p><p class="headingAnchor" id="H13745214"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Immunoglobulin E (IgE) is important in defense against some parasitic diseases, in mast cell and basophil degranulation, and in antigen presentation. IgE is central to the pathogenesis of many allergic diseases. (See <a class="local">'Roles of IgE'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IgE is produced by plasma cells. Isotype switching of B cells to produce antigen-specific IgE requires interleukin (IL-) 4 and IL-13 and interactions between B and T cells. Antigen-specific IgE production primarily takes place in mucosal lymphoid tissues, particularly the tonsils and adenoids. (See <a class="local">'Synthesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IgE functions through its high- (Fc-epsilon-RI) and low- (Fc-epsilon-RII) affinity receptors on mast cells, basophils, and other cells. Binding of IgE to Fc-epsilon-RI leads to degranulation of mast cells and basophils. Binding to Fc-epsilon-RII is important for antigen presentation, B cell differentiation, and regulation of IgE synthesis. Expression of both receptors is positively correlated to circulating IgE levels. (See <a class="local">'IgE receptors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Total IgE levels are frequently measured by a sandwich-type assay. Most assays can only detect IgE levels as low as 2 to 5 international units/mL, with lower levels characterized as undetectable. Normal serum levels range from approximately undetectable to 100 international units/mL. (See <a class="local">'Measurement of IgE'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IgE is not transferred across the placenta. Levels increase from birth and peak between 16 and 19 years of age (<a class="graphic graphic_figure graphicRef83424" href="/d/graphic/83424.html" rel="external">figure 3</a>). (See <a class="local">'IgE levels'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IgE deficiency is defined as levels of total IgE &lt;2.5 international units/mL. Decreased IgE levels can be associated with deficiencies of other immunoglobulins and with sinopulmonary disease and autoimmune diseases, although it is unclear if isolated IgE deficiency in humans is a clinically relevant immunodeficiency or a marker of more general immune dysregulation. (See <a class="local">'Decreased total IgE'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased total serum IgE is seen in allergic diseases, some primary immunodeficiencies, parasitic and viral infections, certain inflammatory diseases, some malignancies, and a few other disorders (<a class="graphic graphic_table graphicRef83457" href="/d/graphic/83457.html" rel="external">table 1</a>). (See <a class="local">'Increased total IgE'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treatments aimed at blocking IgE and decreasing IgE receptor expression are important therapeutic strategies in managing allergic disease. (See  <a class="medical medical_review" href="/d/html/545.html" rel="external">"Anti-IgE therapy"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Oettgen HC. Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases. J Allergy Clin Immunol 2016; 137:1631.</a></li><li><a class="nounderline abstract_t">McSharry C, Xia Y, Holland CV, Kennedy MW. Natural immunity to Ascaris lumbricoides associated with immunoglobulin E antibody to ABA-1 allergen and inflammation indicators in children. Infect Immun 1999; 67:484.</a></li><li><a class="nounderline abstract_t">Lynch NR, Hagel IA, Palenque ME, et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998; 101:217.</a></li><li><a class="nounderline abstract_t">Watanabe N, Katakura K, Kobayashi A, et al. Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis. Proc Natl Acad Sci U S A 1988; 85:4460.</a></li><li><a class="nounderline abstract_t">Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010; 125:S73.</a></li><li><a class="nounderline abstract_t">Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010; 125:S41.</a></li><li><a class="nounderline abstract_t">Arnold JN, Wormald MR, Sim RB, et al. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007; 25:21.</a></li><li><a class="nounderline abstract_t">Vercelli D. Genetic regulation of IgE responses: Achilles and the tortoise. J Allergy Clin Immunol 2005; 116:60.</a></li><li class="breakAll">Vercelli D. Immunobiology of IgE. In: Middleton's allergy: Principles and practice, 7th ed, Adkinson NF, Bochner BS, Busse WW, et al (Eds), Mosby Elsevier, 2009.</li><li><a class="nounderline abstract_t">Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003; 3:721.</a></li><li class="breakAll">Smith P, Ownby DR. Clinical significance of IgE. In: Middleton's allergy: Principles and practice, 7th ed, Adkinson NF, Bochner BS, Busse WW, et al (Eds), Mosby Elsevier, 2009.</li><li><a class="nounderline abstract_t">Eckl-Dorna J, Pree I, Reisinger J, et al. The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells. Clin Exp Allergy 2012; 42:1347.</a></li><li><a class="nounderline abstract_t">Dullaers M, De Bruyne R, Ramadani F, et al. The who, where, and when of IgE in allergic airway disease. J Allergy Clin Immunol 2012; 129:635.</a></li><li><a class="nounderline abstract_t">Colas L, Magnan A, Brouard S. Immunoglobulin E response in health and disease beyond allergic disorders. Allergy 2022; 77:1700.</a></li><li><a class="nounderline abstract_t">Cameron L, Gounni AS, Frenkiel S, et al. S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination. J Immunol 2003; 171:3816.</a></li><li><a class="nounderline abstract_t">Coker HA, Durham SR, Gould HJ. Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 2003; 171:5602.</a></li><li><a class="nounderline abstract_t">Takhar P, Smurthwaite L, Coker HA, et al. Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol 2005; 174:5024.</a></li><li><a class="nounderline abstract_t">Takhar P, Corrigan CJ, Smurthwaite L, et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol 2007; 119:213.</a></li><li><a class="nounderline abstract_t">Balzar S, Strand M, Rhodes D, Wenzel SE. IgE expression pattern in lung: relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol 2007; 119:855.</a></li><li><a class="nounderline abstract_t">Holgate S, Casale T, Wenzel S, et al. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 2005; 115:459.</a></li><li><a class="nounderline abstract_t">Fregonese L, Patel A, van Schadewijk A, et al. Expression of the high-affinity IgE receptor (FcepsilonRI) is increased in fatal asthma. Am J Respir Crit Care 2004; 169:A297.</a></li><li><a class="nounderline abstract_t">Bellou A, Kanny G, Fremont S, Moneret-Vautrin DA. Transfer of atopy following bone marrow transplantation. Ann Allergy Asthma Immunol 1997; 78:513.</a></li><li><a class="nounderline abstract_t">Walker SA, Riches PG, Wild G, et al. Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation. Clin Exp Immunol 1986; 66:633.</a></li><li><a class="nounderline abstract_t">Saarinen UM. Transfer of latent atopy by bone marrow transplantation? A case report. J Allergy Clin Immunol 1984; 74:196.</a></li><li><a class="nounderline abstract_t">Agosti JM, Sprenger JD, Lum LG, et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988; 319:1623.</a></li><li><a class="nounderline abstract_t">Hallstrand TS, Sprenger JD, Agosti JM, et al. Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood 2004; 104:3086.</a></li><li><a class="nounderline abstract_t">Weidinger S, Gieger C, Rodriguez E, et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 2008; 4:e1000166.</a></li><li><a class="nounderline abstract_t">Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363:1211.</a></li><li><a class="nounderline abstract_t">Granada M, Wilk JB, Tuzova M, et al. A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study. J Allergy Clin Immunol 2012; 129:840.</a></li><li><a class="nounderline abstract_t">Niederberger V, Ring J, Rakoski J, et al. Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol 2007; 142:133.</a></li><li><a class="nounderline abstract_t">Egger C, Horak F, Vrtala S, et al. Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses. J Allergy Clin Immunol 2010; 126:1312.</a></li><li><a class="nounderline abstract_t">Shade KT, Platzer B, Washburn N, et al. A single glycan on IgE is indispensable for initiation of anaphylaxis. J Exp Med 2015; 212:457.</a></li><li><a class="nounderline abstract_t">Moñino-Romero S, Erkert L, Schmidthaler K, et al. The soluble isoform of human FcɛRI is an endogenous inhibitor of IgE-mediated mast cell responses. Allergy 2019; 74:236.</a></li><li><a class="nounderline abstract_t">Hibbert RG, Teriete P, Grundy GJ, et al. The structure of human CD23 and its interactions with IgE and CD21. J Exp Med 2005; 202:751.</a></li><li><a class="nounderline abstract_t">Tsicopoulos A, Joseph M. The role of CD23 in allergic disease. Clin Exp Allergy 2000; 30:602.</a></li><li><a class="nounderline abstract_t">Selb R, Eckl-Dorna J, Twaroch TE, et al. Critical and direct involvement of the CD23 stalk region in IgE binding. J Allergy Clin Immunol 2017; 139:281.</a></li><li><a class="nounderline abstract_t">Cooper AM, Hobson PS, Jutton MR, et al. Soluble CD23 controls IgE synthesis and homeostasis in human B cells. J Immunol 2012; 188:3199.</a></li><li><a class="nounderline abstract_t">Poole JA, Meng J, Reff M, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol 2005; 116:780.</a></li><li><a class="nounderline abstract_t">Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008; 100:S1.</a></li><li><a class="nounderline abstract_t">Hamilton RG, Franklin Adkinson N Jr. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol 2004; 114:213.</a></li><li><a class="nounderline abstract_t">Hamilton RG, Williams PB, Specific IgE Testing Task Force of the American Academy of Allergy, Asthma &amp; Immunology, American College of Allergy, Asthma and Immunology. Human IgE antibody serology: a primer for the practicing North American allergist/immunologist. J Allergy Clin Immunol 2010; 126:33.</a></li><li><a class="nounderline abstract_t">Thorpe SJ, Heath A, Fox B, et al. The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation. Clin Chem Lab Med 2014; 52:1283.</a></li><li><a class="nounderline abstract_t">Hamilton RG. Accuracy of US Food and Drug Administration-cleared IgE antibody assays in the presence of anti-IgE (omalizumab). J Allergy Clin Immunol 2006; 117:759.</a></li><li><a class="nounderline abstract_t">Martins TB, Bandhauer ME, Bunker AM, et al. New childhood and adult reference intervals for total IgE. J Allergy Clin Immunol 2014; 133:589.</a></li><li><a class="nounderline abstract_t">Kamemura N, Tada H, Shimojo N, et al. Intrauterine sensitization of allergen-specific IgE analyzed by a highly sensitive new allergen microarray. J Allergy Clin Immunol 2012; 130:113.</a></li><li><a class="nounderline abstract_t">Gergen PJ, Arbes SJ Jr, Calatroni A, et al. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2009; 124:447.</a></li><li><a class="nounderline abstract_t">Underdown BJ, Knight A, Papsin FR. The relative paucity of IgE in human milk. J Immunol 1976; 116:1435.</a></li><li><a class="nounderline abstract_t">Duchén K, Björkstén B. Total IgE levels in human colostrum. Pediatr Allergy Immunol 1996; 7:44.</a></li><li><a class="nounderline abstract_t">Wright AL, Sherrill D, Holberg CJ, et al. Breast-feeding, maternal IgE, and total serum IgE in childhood. J Allergy Clin Immunol 1999; 104:589.</a></li><li><a class="nounderline abstract_t">Schoettler JJ, Schleissner LA, Heiner DC. Familial IgE deficiency associated with sinopulmonary disease. Chest 1989; 96:516.</a></li><li><a class="nounderline abstract_t">Smith JK, Krishnaswamy GH, Dykes R, et al. Clinical manifestations of IgE hypogammaglobulinemia. Ann Allergy Asthma Immunol 1997; 78:313.</a></li><li><a class="nounderline abstract_t">Mogensen TH. Primary Immunodeficiencies with Elevated IgE. Int Rev Immunol 2016; 35:39.</a></li><li><a class="nounderline abstract_t">Pien GC, Orange JS. Evaluation and clinical interpretation of hypergammaglobulinemia E: differentiating atopy from immunodeficiency. Ann Allergy Asthma Immunol 2008; 100:392.</a></li><li><a class="nounderline abstract_t">Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008; 122:1054.</a></li><li><a class="nounderline abstract_t">Al-Shaikhly T, Ochs HD. Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol 2019; 97:368.</a></li><li><a class="nounderline abstract_t">Ponsford MJ, Klocperk A, Pulvirenti F, et al. Hyper-IgE in the allergy clinic--when is it primary immunodeficiency? Allergy 2018; 73:2122.</a></li><li><a class="nounderline abstract_t">Duarte J, Deshpande P, Guiyedi V, et al. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Malar J 2007; 6:1.</a></li><li><a class="nounderline abstract_t">Varatharajalu R, Parandaman V, Ndao M, et al. Strongyloides stercoralis excretory/secretory protein strongylastacin specifically recognized by IgE antibodies in infected human sera. Microbiol Immunol 2011; 55:115.</a></li><li><a class="nounderline abstract_t">Zar HJ, Latief Z, Hughes J, Hussey G. Serum immunoglobulin E levels in human immunodeficiency virus-infected children with pneumonia. Pediatr Allergy Immunol 2002; 13:328.</a></li><li><a class="nounderline abstract_t">Bowser CS, Kaye J, Joks RO, et al. IgE and atopy in perinatally HIV-infected children. Pediatr Allergy Immunol 2007; 18:298.</a></li><li><a class="nounderline abstract_t">Miguez-Burbano MJ, Shor-Posner G, Fletcher MA, et al. Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E status. Allergy 1995; 50:157.</a></li><li><a class="nounderline abstract_t">Bahna SL, Heiner DC, Horwitz CA. Sequential changes of the five immunoglobulin classes and other responses in infectious mononucleosis. Int Arch Allergy Appl Immunol 1984; 74:1.</a></li><li><a class="nounderline abstract_t">Ellertsen LK, Storla DG, Diep LM, et al. Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy. BMC Infect Dis 2009; 9:100.</a></li><li><a class="nounderline abstract_t">Kutlu A, Bozkanat E, Ciftçi F, et al. Effect of active tuberculosis on skin prick allergy tests and serum IgE levels. J Investig Allergol Clin Immunol 2008; 18:113.</a></li><li><a class="nounderline abstract_t">Ohrui T, Zayasu K, Sato E, et al. Pulmonary tuberculosis and serum IgE. Clin Exp Immunol 2000; 122:13.</a></li><li><a class="nounderline abstract_t">Abuel-Haija M, Hurford MT. Kimura disease. Arch Pathol Lab Med 2007; 131:650.</a></li><li><a class="nounderline abstract_t">Eckschlager T, Průsa R, Hladíková M, et al. Lymphocyte subpopulations and immunoglobulin levels in Hodgkin's disease survivors. Neoplasma 2004; 51:261.</a></li><li><a class="nounderline abstract_t">Koutsonikolis A, Day N, Chamizo W, et al. Asymptomatic lymphoma associated with elevation of immunoglobulin E. Ann Allergy Asthma Immunol 1997; 78:27.</a></li><li><a class="nounderline abstract_t">Miyake S, Yoshizawa Y, Ohkouchi Y, et al. Non-Hodgkin's lymphoma with pulmonary infiltrates mimicking miliary tuberculosis. Intern Med 1997; 36:420.</a></li><li><a class="nounderline abstract_t">Young MC, Harfi H, Sabbah R, et al. A human T cell lymphoma secreting an immunoglobulin E specific helper factor. J Clin Invest 1985; 75:1977.</a></li><li><a class="nounderline abstract_t">Scala E, Abeni D, Palazzo P, et al. Specific IgE toward allergenic molecules is a new prognostic marker in patients with Sézary syndrome. Int Arch Allergy Immunol 2012; 157:159.</a></li><li><a class="nounderline abstract_t">Kural YB, Su O, Onsun N, Uras AR. Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma. Int J Dermatol 2010; 49:390.</a></li><li><a class="nounderline abstract_t">Talamo G, Castellani W, Dolloff NG. Prozone effect of serum IgE levels in a case of plasma cell leukemia. J Hematol Oncol 2010; 3:32.</a></li><li><a class="nounderline abstract_t">Takemura Y, Ikeda M, Kobayashi K, et al. Plasma cell leukemia producing monoclonal immunoglobulin E. Int J Hematol 2009; 90:402.</a></li><li><a class="nounderline abstract_t">Hua J, Hagihara M, Inoue M, Iwaki Y. A case of IgE-multiple myeloma presenting with a high serum Krebs von den Lungen-6 level. Leuk Res 2012; 36:e107.</a></li><li><a class="nounderline abstract_t">Lloyd L, Klingberg SL, Kende M, et al. A case of IgE multiple myeloma. Pathology 2003; 35:87.</a></li><li><a class="nounderline abstract_t">Wang ML, Huang Q, Yang TX. IgE myeloma with elevated level of serum CA125. J Zhejiang Univ Sci B 2009; 10:559.</a></li><li><a class="nounderline abstract_t">Ringdén O, Persson U, Johansson SG, et al. Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood 1983; 61:1190.</a></li><li><a class="nounderline abstract_t">Geha RS, Rappaport JM, Twarog FJ, et al. Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation. J Allergy Clin Immunol 1980; 66:78.</a></li><li><a class="nounderline abstract_t">Tan Y, Yang D, Fan J, Chen Y. Elevated levels of immunoglobulin E may indicate steroid resistance or relapse in adult primary nephrotic syndrome, especially in minimal change nephrotic syndrome. J Int Med Res 2011; 39:2307.</a></li><li><a class="nounderline abstract_t">Jahan I, Hanif M, Ali MA, et al. Relationship between serum IgE and frequent relapse idiopathic nephrotic syndrome. Mymensingh Med J 2011; 20:484.</a></li><li><a class="nounderline abstract_t">Shao YN, Chen YC, Jenq CC, et al. Serum immunoglobulin E can predict minimal change disease before renal biopsy. Am J Med Sci 2009; 338:264.</a></li><li><a class="nounderline abstract_t">Bonnin AJ, Montealegre F, Gewurz A. Association of cigarette smoking with elevated serum IgE levels in Hispanic Puerto Rican men. Ann Allergy 1991; 67:609.</a></li><li><a class="nounderline abstract_t">Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34:J258.</a></li><li><a class="nounderline abstract_t">González-Quintela A, Vidal C, Gude F. Alcohol-induced alterations in serum immunoglobulin e (IgE) levels in human subjects. Front Biosci 2002; 7:e234.</a></li><li><a class="nounderline abstract_t">Friedrich N, Husemoen LL, Petersmann A, et al. The association between alcohol consumption and biomarkers of alcohol exposure with total serum immunoglobulin E levels. Alcohol Clin Exp Res 2008; 32:983.</a></li><li><a class="nounderline abstract_t">Lomholt FK, Nielsen SF, Nordestgaard BG. High alcohol consumption causes high IgE levels but not high risk of allergic disease. J Allergy Clin Immunol 2016; 138:1404.</a></li></ol></div><div id="topicVersionRevision">Topic 5542 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27263999" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9916049" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Natural immunity to Ascaris lumbricoides associated with immunoglobulin E antibody to ABA-1 allergen and inflammation indicators in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9500755" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3380800" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20176269" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : IgE, mast cells, basophils, and eosinophils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20176268" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Structure and function of immunoglobulins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17029568" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The impact of glycosylation on the biological function and structure of human immunoglobulins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15990775" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Genetic regulation of IgE responses: Achilles and the tortoise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15990775" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Genetic regulation of IgE responses: Achilles and the tortoise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12949496" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The regulation of immunoglobulin E class-switch recombination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12949496" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The regulation of immunoglobulin E class-switch recombination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22925321" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22168998" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The who, where, and when of IgE in allergic airway disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35073421" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Immunoglobulin E response in health and disease beyond allergic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14500683" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14607969" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15814733" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17208604" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17321582" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : IgE expression pattern in lung: relation to systemic IgE and asthma phenotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15753888" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Expression of the high-affinity IgE receptor (FcepsilonRI) is increased in fatal asthma</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9164366" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Transfer of atopy following bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2436842" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6379019" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Transfer of latent atopy by bone marrow transplantation? A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3059190" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15280196" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18846228" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20860503" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A large-scale, consortium-based genomewide association study of asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22075330" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17057411" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Antigens drive memory IgE responses in human allergy via the nasal mucosa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20673979" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25824821" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A single glycan on IgE is indispensable for initiation of anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30030936" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The soluble isoform of human FcɛRI is an endogenous inhibitor of IgE-mediated mast cell responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16172256" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The structure of human CD23 and its interactions with IgE and CD21.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10792350" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The role of CD23 in allergic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27343203" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Critical and direct involvement of the CD23 stalk region in IgE binding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22393152" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Soluble CD23 controls IgE synthesis and homeostasis in human B cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210051" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18431959" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Allergy diagnostic testing: an updated practice parameter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15316492" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : In vitro assays for the diagnosis of IgE-mediated disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20451984" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Human IgE antibody serology: a primer for the practicing North American allergist/immunologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24807170" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16630931" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Accuracy of US Food and Drug Administration-cleared IgE antibody assays in the presence of anti-IgE (omalizumab).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24139495" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : New childhood and adult reference intervals for total IgE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22464644" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Intrauterine sensitization of allergen-specific IgE analyzed by a highly sensitive new allergen microarray.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19647861" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/946811" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The relative paucity of IgE in human milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8792383" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Total IgE levels in human colostrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10482832" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Breast-feeding, maternal IgE, and total serum IgE in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2766811" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Familial IgE deficiency associated with sinopulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9087159" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Clinical manifestations of IgE hypogammaglobulinemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25970001" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Primary Immunodeficiencies with Elevated IgE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18450128" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Evaluation and clinical interpretation of hypergammaglobulinemia E: differentiating atopy from immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19084106" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Primary immune deficiencies with aberrant IgE production.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30264496" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Hyper IgE syndromes: clinical and molecular characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30043993" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Hyper-IgE in the allergy clinic--when is it primary immunodeficiency?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17204149" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21204942" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Strongyloides stercoralis excretory/secretory protein strongylastacin specifically recognized by IgE antibodies in infected human sera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12431191" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Serum immunoglobulin E levels in human immunodeficiency virus-infected children with pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17355242" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : IgE and atopy in perinatally HIV-infected children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7604939" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6706423" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Sequential changes of the five immunoglobulin classes and other responses in infectious mononucleosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19558655" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18447140" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effect of active tuberculosis on skin prick allergy tests and serum IgE levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11012611" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Pulmonary tuberculosis and serum IgE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17425383" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Kimura disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15254656" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Lymphocyte subpopulations and immunoglobulin levels in Hodgkin's disease survivors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9012616" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Asymptomatic lymphoma associated with elevation of immunoglobulin E.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9213190" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Non-Hodgkin's lymphoma with pulmonary infiltrates mimicking miliary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3159754" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : A human T cell lymphoma secreting an immunoglobulin E specific helper factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21985996" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Specific IgE toward allergenic molecules is a new prognostic marker in patients with Sézary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20465692" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20828419" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prozone effect of serum IgE levels in a case of plasma cell leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19728026" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Plasma cell leukemia producing monoclonal immunoglobulin E.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22425660" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : A case of IgE-multiple myeloma presenting with a high serum Krebs von den Lungen-6 level.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12701695" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A case of IgE multiple myeloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19585675" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : IgE myeloma with elevated level of serum CA125.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6340757" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6991585" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22289548" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Elevated levels of immunoglobulin E may indicate steroid resistance or relapse in adult primary nephrotic syndrome, especially in minimal change nephrotic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21804516" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Relationship between serum IgE and frequent relapse idiopathic nephrotic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19707110" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Serum immunoglobulin E can predict minimal change disease before renal biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1750725" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Association of cigarette smoking with elevated serum IgE levels in Hispanic Puerto Rican men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20042314" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Effects of tobacco smoke on immunity, inflammation and autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11991851" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Alcohol-induced alterations in serum immunoglobulin e (IgE) levels in human subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18445104" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The association between alcohol consumption and biomarkers of alcohol exposure with total serum immunoglobulin E levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27464961" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : High alcohol consumption causes high IgE levels but not high risk of allergic disease.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
